Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease
Author:
Funder
Takeda Pharmaceutical Company
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference39 articles.
1. Crohn's disease;Baumgart;Lancet,2012
2. Vedolizumab as induction and maintenance therapy for Crohn's disease;Sandborn;N Engl J Med,2013
3. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed;Sands;Gastroenterology,2014
4. Vedolizumab induces long-term mucosal healing in patients with Crohn's disease and ulcerative colitis;Noman;J Crohns Colitis,2017
5. The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: results from the US VICTORY Consortium;Dulai;Am J Gastroenterol,2016
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease;Expert Review of Gastroenterology & Hepatology;2023-12-02
2. Understanding the molecular mechanisms of anti-trafficking therapies and their clinical relevance in inflammatory bowel disease;Mucosal Immunology;2023-12
3. FISTULIZING PERIANAL CROHN’S DISEASE: IS THE PATIENT’S SEX A BURDEN? A SYSTEMATIC REVIEW;Arquivos de Gastroenterologia;2023-11
4. Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial;Clinical Gastroenterology and Hepatology;2023-11
5. Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease;Journal of Clinical Medicine;2023-10-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3